Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl versus magnesium sulfate by intrathecal or intra-articular administration for pain after knee arthroscopy
IRCT20141209020258N181Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl, magnesium sulfate and bupivacaine in postoperative pain (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Pain and Average analgesic drug consumption. Started Mar 2023; status: completed.
02
Drugs
fentanylmagnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20141209020258N181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N181.